• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心血管疾病连续体治疗的新范式:聚焦预防。

A new paradigm in the treatment of the cardiovascular disease continuum: focus on prevention.

作者信息

Chrysant S G

机构信息

Oklahoma Cardiovascular and Hypertension Center, Oklahoma City, Oklahoma, USA.

出版信息

Hippokratia. 2011 Jan;15(1):7-11.

PMID:21607028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3093150/
Abstract

The cardiovascular disease continuum (CVDC) is a sequence of cardiovascular events, which begins from a cluster of cardiovascular risk factors consisting of diabetes mellitus, dyslipidemia, hypertension, smoking and visceral obesity. If these factors are not intervened with early, they will, inexorably, progress to atherosclerosis, coronary artery disease, myocardial infarction, left ventricular hypertrophy, left ventricular dilatation leading to left ventricular diastolic or systolic dysfunction and eventually end stage heart failure and death. For this concise review, a Medline search of the English language literature between the years 2000 and 2009 was conducted and 33 pertinent publications were selected. Based on the evidence contained in these publications, it is possible that early intervention and treatment of the various cardiovascular risk factors, which initiate and perpetuate the CVDC, could prevent it or arrest its further progress. Therefore, this concise review will emphasize the early detection and treatment of the various cardiovascular risk factors, which initiate and perpetuate the CVDC.

摘要

心血管疾病连续体(CVDC)是一系列心血管事件,始于由糖尿病、血脂异常、高血压、吸烟和内脏肥胖组成的心血管危险因素群。如果这些因素不及早干预,它们将不可避免地发展为动脉粥样硬化、冠状动脉疾病、心肌梗死、左心室肥厚、左心室扩张,导致左心室舒张或收缩功能障碍,最终发展为终末期心力衰竭和死亡。为了进行这篇简要综述,我们对2000年至2009年期间的英文文献进行了Medline检索,并选择了33篇相关出版物。基于这些出版物中包含的证据,对启动并使CVDC持续存在的各种心血管危险因素进行早期干预和治疗,有可能预防CVDC或阻止其进一步发展。因此,这篇简要综述将强调对启动并使CVDC持续存在的各种心血管危险因素进行早期检测和治疗。

相似文献

1
A new paradigm in the treatment of the cardiovascular disease continuum: focus on prevention.心血管疾病连续体治疗的新范式:聚焦预防。
Hippokratia. 2011 Jan;15(1):7-11.
2
Stopping the cardiovascular disease continuum: Focus on prevention.阻断心血管疾病的发展进程:聚焦预防。
World J Cardiol. 2010 Mar 26;2(3):43-9. doi: 10.4330/wjc.v2.i3.43.
3
The treatment of cardiovascular disease continuum: focus on prevention and RAS blockade.
Curr Clin Pharmacol. 2010 May;5(2):89-95. doi: 10.2174/157488410791110742.
4
Angiotensin II receptor blockers in the treatment of the cardiovascular disease continuum.血管紧张素II受体阻滞剂在心血管疾病连续体治疗中的应用
Clin Ther. 2008;30 Pt 2:2181-90. doi: 10.1016/j.clinthera.2008.12.002.
5
From hypertension to heart failure: update on the management of systolic and diastolic dysfunction.
Am J Hypertens. 2003 Sep;16(9 Pt 2):18S-22S. doi: 10.1016/s0895-7061(03)00966-x.
6
Hazards, risks, and threats of heart disease from the early stages to symptomatic coronary heart disease and cardiac failure.从早期阶段到症状性冠心病和心力衰竭的心脏病的危害、风险和威胁。
Cardiovasc Drugs Ther. 1997 May;11 Suppl 1:199-212. doi: 10.1023/a:1007792820944.
7
Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.组织血管紧张素转换酶抑制剂用于预防无左心室收缩功能障碍或心力衰竭临床证据的糖尿病患者心血管疾病:随机安慰剂对照临床试验的汇总荟萃分析
Diabetes Obes Metab. 2008 Jan;10(1):41-52. doi: 10.1111/j.1463-1326.2006.00688.x.
8
Cohort profile: Copenhagen Hospital Biobank - Cardiovascular Disease Cohort (CHB-CVDC): Construction of a large-scale genetic cohort to facilitate a better understanding of heart diseases.队列资料简介:哥本哈根医院生物银行 - 心血管疾病队列(CHB-CVDC):构建一个大规模的遗传队列,以促进更好地了解心脏疾病。
BMJ Open. 2021 Dec 30;11(12):e049709. doi: 10.1136/bmjopen-2021-049709.
9
The incremental prognostic value of echocardiography in asymptomatic stage a heart failure.超声心动图在无症状 A 期心力衰竭中的预后增值。
J Am Soc Echocardiogr. 2010 Oct;23(10):1025-34. doi: 10.1016/j.echo.2010.06.017. Epub 2010 Jul 24.
10
Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.冠心病且无心力衰竭或左心室收缩功能障碍患者使用血管紧张素转换酶抑制剂:长期随机对照试验综述
Arch Intern Med. 2006 Apr 10;166(7):787-96. doi: 10.1001/archinte.166.7.787.

引用本文的文献

1
Optimizing Cardiovascular Outcomes With Bisoprolol: An Evidence-Based Perspective.从循证角度看比索洛尔对心血管结局的优化作用
Cureus. 2025 Aug 7;17(8):e89579. doi: 10.7759/cureus.89579. eCollection 2025 Aug.
2
Prediabetes in a French overseas territory: Clinical Characteristics, Risk Factors, and Implications for type 2 diabetes prevention.法国海外领土的糖尿病前期:临床特征、危险因素及对2型糖尿病预防的意义。
Prev Med Rep. 2024 Sep 25;47:102893. doi: 10.1016/j.pmedr.2024.102893. eCollection 2024 Nov.
3
Awareness of Hypertension, Hypercholesterolemia, and Diabetes Mellitus and Associated Characteristics in Russian Adults.俄罗斯成年人对高血压、高胆固醇血症和糖尿病的知晓情况及相关特征
Int J Hypertens. 2024 Mar 25;2024:8542671. doi: 10.1155/2024/8542671. eCollection 2024.
4
Detection of heart rate using smartphone gyroscope data: a scoping review.利用智能手机陀螺仪数据检测心率:一项综述
Front Cardiovasc Med. 2023 Dec 18;10:1329290. doi: 10.3389/fcvm.2023.1329290. eCollection 2023.
5
Spatial and temporal trends of overweight/obesity and tobacco use in East Africa: subnational insights into cardiovascular disease risk factors.东非超重/肥胖和烟草使用的时空趋势:心血管疾病风险因素的国家以下层面见解。
Int J Health Geogr. 2023 Aug 24;22(1):20. doi: 10.1186/s12942-023-00342-7.
6
A cost-effectiveness analysis of risk-based intervention for prevention of cardiovascular diseases in IraPEN program: A modeling study.基于风险的干预措施预防 IraPEN 项目中心血管疾病的成本效益分析:一项建模研究。
Front Public Health. 2023 Feb 24;11:1075277. doi: 10.3389/fpubh.2023.1075277. eCollection 2023.
7
Chinese Herbal Medicine Reduces the Risk of Heart Failure in Hypertensive Patients: A Nationwide, Retrospective, Cohort Study.中药降低高血压患者心力衰竭风险:一项全国性回顾性队列研究。
Front Cardiovasc Med. 2022 Jul 11;9:922728. doi: 10.3389/fcvm.2022.922728. eCollection 2022.
8
Echocardiographic Characterization of Left Ventricular Structure, Function, and Coronary Flow in Neonate Mice.超声心动图对新生小鼠左心室结构、功能和冠状动脉血流的特征分析。
J Vis Exp. 2022 Apr 7(182). doi: 10.3791/63539.
9
Developing a Sustainable Cardiovascular Disease Research Strategy in Tanzania Through Training: Leveraging From the East African Centre of Excellence in Cardiovascular Sciences Project.通过培训在坦桑尼亚制定可持续的心血管疾病研究战略:借鉴东非心血管科学卓越中心项目的经验。
Front Cardiovasc Med. 2022 Mar 25;9:849007. doi: 10.3389/fcvm.2022.849007. eCollection 2022.
10
Blood Pressure Sensors: Materials, Fabrication Methods, Performance Evaluations and Future Perspectives.血压传感器:材料、制造方法、性能评估及未来展望。
Sensors (Basel). 2020 Aug 11;20(16):4484. doi: 10.3390/s20164484.

本文引用的文献

1
Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women.除了低密度脂蛋白胆固醇之外:非高密度脂蛋白胆固醇水平、甘油三酯以及总胆固醇/高密度脂蛋白胆固醇比值对貌似健康的男性和女性冠心病风险的各自影响。
J Am Coll Cardiol. 2009 Dec 29;55(1):35-41. doi: 10.1016/j.jacc.2009.07.057.
2
Smoking status and long-term survival after first acute myocardial infarction a population-based cohort study.吸烟状况与首次急性心肌梗死后的长期生存:一项基于人群的队列研究。
J Am Coll Cardiol. 2009 Dec 15;54(25):2382-7. doi: 10.1016/j.jacc.2009.09.020.
3
Total cardiovascular disease burden: comparing intensive with moderate statin therapy insights from the IDEAL (Incremental Decrease in End Points Through Aggressive Lipid Lowering) trial.总体心血管疾病负担:比较强化与中等强度他汀治疗——来自 IDEAL(通过强化降脂降低终点事件发生率)试验的见解。
J Am Coll Cardiol. 2009 Dec 15;54(25):2353-7. doi: 10.1016/j.jacc.2009.08.035.
4
The association of pediatric low- and high-density lipoprotein cholesterol dyslipidemia classifications and change in dyslipidemia status with carotid intima-media thickness in adulthood evidence from the cardiovascular risk in Young Finns study, the Bogalusa Heart study, and the CDAH (Childhood Determinants of Adult Health) study.儿童低密度和高密度脂蛋白胆固醇血脂异常分类以及血脂异常状态变化与成年期颈动脉内膜中层厚度的关联:来自芬兰青年人心血管风险研究、博加卢萨心脏研究和成人健康儿童决定因素(CDAH)研究的证据
J Am Coll Cardiol. 2009 Mar 10;53(10):860-9. doi: 10.1016/j.jacc.2008.09.061.
5
Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy.直接肾素抑制剂阿利吉仑、血管紧张素受体阻滞剂氯沙坦或两者联用对高血压合并左心室肥厚患者左心室质量的影响。
Circulation. 2009 Feb 3;119(4):530-7. doi: 10.1161/CIRCULATIONAHA.108.826214. Epub 2009 Jan 19.
6
A comprehensive review on salt and health and current experience of worldwide salt reduction programmes.关于盐与健康的全面综述以及全球减盐计划的当前经验。
J Hum Hypertens. 2009 Jun;23(6):363-84. doi: 10.1038/jhh.2008.144. Epub 2008 Dec 25.
7
Population-based prevention of obesity: the need for comprehensive promotion of healthful eating, physical activity, and energy balance: a scientific statement from American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention (formerly the expert panel on population and prevention science).基于人群的肥胖预防:全面促进健康饮食、身体活动和能量平衡的必要性:美国心脏协会流行病学与预防委员会、跨学科预防委员会(原人群与预防科学专家小组)的科学声明
Circulation. 2008 Jul 22;118(4):428-64. doi: 10.1161/CIRCULATIONAHA.108.189702. Epub 2008 Jun 30.
8
The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.PHARAO研究:血管紧张素转换酶抑制剂雷米普利预防血压正常高值患者高血压:德国高血压联盟的一项前瞻性、随机、对照预防试验
J Hypertens. 2008 Jul;26(7):1487-96. doi: 10.1097/HJH.0b013e3282ff8864.
9
Development of heart failure in recent hypertension trials.近期高血压试验中心力衰竭的发展情况。
J Hypertens. 2008 Jul;26(7):1477-86. doi: 10.1097/HJH.0b013e3282fe1d3d.
10
The early life origins of vascular ageing and cardiovascular risk: the EVA syndrome.血管衰老和心血管风险的早期生命起源:EVA综合征
J Hypertens. 2008 Jun;26(6):1049-57. doi: 10.1097/HJH.0b013e3282f82c3e.